Table 3.
CD103 and CD123 Expression in B-Cell Lymphoproliferative Disorders
Diagnosis | CD103+/CD123− | CD123+/CD103− | CD103+/CD123+ | CD103−/CD123− | Total |
---|---|---|---|---|---|
HCL | 0 | 0 | 114 | 0 | 114 |
HCLv | 12 | 0 | 8 | 0 | 20 |
SMZL* | 0 | 1 | 0 | 3 | 4 |
MCL | 0 | 7 | 0 | 14 | 21 |
CLL | 0 | 5 | 0 | 128 | 133 |
FL | 0 | 1 | 0 | 2 | 3 |
CLL, chronic lymphocytic leukemia; FL, follicular lymphoma; HCL, hairy celi leukemia; HCLv, HCL variant; MCL, mantle celi lymphoma; SMZL, splenic marginal zone lymphoma.
5 additional SMZL cases were evaluated for CD103 only; all 5 were negative.